11 Quintanrix blev administreret til cirka 1, 340 raske spædbørn fra 6 ugers alderen som et primært vaccinationsprogram i adskillelige kliniske studier.
Quintanrix was administered to approximately 1,340 healthy infants from 6 weeks of age as a primary vaccination course in several clinical trials.